Related Experiment Videos
[Optimized diabetes therapy in type 2 diabetics]
Andreas Clemens1, Jürgen F Riemann, Erhard G Siegel
1Medizinische Klinik C, Stoffwechselzentrum des Klinikums der Stadt Ludwigshafen, Ludwigshafen. a_clemens@gmx.de
Medizinische Klinik (Munich, Germany : 1983)
|October 11, 2003
Summary
Type 2 diabetes is a growing European health concern. This review outlines evidence-based glycemic control guidelines and functional insulin therapy (FIT) for managing type 2 diabetes mellitus.
Area of Science:
- Endocrinology
- Public Health
Background:
- Type 2 diabetes mellitus (T2DM) prevalence is rising globally, posing a significant healthcare challenge.
- In Germany, T2DM affects approximately 8 million individuals, with an estimated 4 million undiagnosed cases.
Purpose of the Study:
- To summarize current therapeutic options for glycemic control in type 2 diabetes.
- To present evidence-based treatment recommendations from a newly developed national guideline.
- To discuss functional insulin therapy (FIT) and innovative insulin delivery methods.
Main Methods:
- Review of a national guideline developed by multiple German medical societies.
- Application of evidence-based medicine criteria for treatment recommendations.
- Focus on glycemic control strategies for type 2 diabetes.
Main Results:
- The guideline provides evidence-based recommendations for T2DM management.
- Functional insulin therapy (FIT) is highlighted as a modern treatment option.
- Innovative insulin application methods are considered.
Conclusions:
- Optimal glycemic control is crucial for minimizing long-term healthcare costs associated with T2DM complications.
- Adherence to evidence-based guidelines and exploring advanced therapies like FIT are essential for effective T2DM management.